Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-254750.0%
operating margin TTM
-255950.0%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -1.17 |
| peg ratio | 0.27 |
| price to book ratio | -1.27 |
| price to sales ratio | 4,588.36 |
| enterprise value multiple | -1.65 |
| price fair value | -1.27 |
profitability ratios | |
|---|---|
| gross profit margin | 62.5% |
| operating profit margin | -255950.0% |
| pretax profit margin | -254750.0% |
| net profit margin | -254750.0% |
| return on assets | -456.75% |
| return on equity | 127.35% |
| return on capital employed | 129.29% |
liquidity ratio | |
|---|---|
| current ratio | 0.20 |
| quick ratio | 0.20 |
| cash ratio | 0.08 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 273.75 |
| days of payables outstanding | 592,030.00 |
| cash conversion cycle | -591,756.25 |
| receivables turnover | 1.33 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.49 |
| debt equity ratio | -0.35 |
| long term debt to capitalization | -0.19 |
| total debt to capitalization | -0.55 |
| interest coverage | -66.05 |
| cash flow to debt ratio | -1.85 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.15 |
| cash per share | 0.15 |
| operating cash flow per share | -1.13 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -1.85 |
| short term coverage ratios | -3.36 |
| capital expenditure coverage ratio | -3,091.25 |
Frequently Asked Questions
When was the last time NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) reported earnings?
NRx Pharmaceuticals, Inc. (NRXP) published its most recent earnings results on 14-11-2024.
What is NRx Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)'s trailing twelve months ROE is 127.35%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. NRx Pharmaceuticals, Inc. (NRXP) currently has a ROA of -456.75%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did NRXP's net profit margin stand at?
NRXP reported a profit margin of -254750.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is NRXP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.20 in the most recent quarter. The quick ratio stood at 0.20, with a Debt/Eq ratio of -0.35.